XML 151 R136.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities $ 181,834 $ 131,586 $ 97,636
Cash flows from investing activities:      
Sale of investment securities 18,628 28,761 116,070
Maturities of investment securities 24,719 101,097 10,822
Purchase of investment securities (34,445) (132,654) (117,211)
Proceeds from sale or liquidation of long-term investments 19,487 966 4,552
Purchase of long-term investments (415) (32,510) (50)
Investments in real estate ventures (9,728) (38,807) (44,107)
Distributions from real estate ventures 54,233 61,718 33,204
Increase in cash surrender value of life insurance policies (764) (802) (484)
Decrease in restricted assets 526 2,250 410
Issuance of notes receivable (450) (1,633) 0
Investments in subsidiaries 0 0 0
Proceeds from sale of fixed assets 9 76 45
Cash acquired in purchase of subsidiaries 654    
Purchase of subsidiaries (10,404) (6,569) (250)
Repayment of notes receivable 67 0 4,410
Capital expenditures (17,682) (19,869) (26,691)
Investments in real estate, net (2,583) (619) (245)
Pay downs of investment securities 1,611 2,633 9,212
Net cash provided by (used in) investing activities 43,463 (35,962) (10,313)
Cash flows from financing activities:      
Proceeds from issuance of debt 325,000 850,021 243,620
Deferred financing costs (9,400) (19,200) (6,600)
Repayments of debt (28,689) (837,205) (5,365)
Borrowings under revolver 307,023 157,630 144,294
Repayments on revolver (310,551) (163,474) (110,614)
Capital contributions received 0 0 0
Intercompany dividends paid 0 0 0
Dividends and distributions on common stock (225,367) (211,488) (198,947)
Distributions to non-controlling interest (2,521) (2,779) (11,545)
Contributions from non-controlling interest 0 0 248
Proceeds from the issuance of Vector stock 0 43,230 0
Proceeds from exercise of Vector options 0 0 398
Tax benefit of options exercised 0 0 579
Net cash provided by (used in) financing activities 55,495 (183,265) 56,068
Net increase (decrease) in cash, cash equivalents and restricted cash 280,792 (87,641) 143,391
Cash, cash equivalents and restricted cash, beginning of year 310,937 398,578 255,187
Cash and cash equivalents and restricted cash, end of year 591,729 310,937 398,578
Consolidating Adjustments      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities (248,091) (275,997) (238,648)
Cash flows from investing activities:      
Sale of investment securities 0 0 0
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0 0
Proceeds from sale or liquidation of long-term investments 0 0 0
Purchase of long-term investments 0 0 0
Investments in real estate ventures 0 0 0
Distributions from real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies 0 0 0
Decrease in restricted assets 0 0 0
Issuance of notes receivable 0 20,000  
Investments in subsidiaries 27,224 38,458 19,219
Proceeds from sale of fixed assets 0 0 0
Cash acquired in purchase of subsidiaries 0    
Purchase of subsidiaries 0 0 0
Repayment of notes receivable (20,000)   0
Capital expenditures 0 0 0
Investments in real estate, net 0 0 0
Pay downs of investment securities 0 0 0
Net cash provided by (used in) investing activities 7,224 58,458 19,219
Cash flows from financing activities:      
Proceeds from issuance of debt 0 (20,000) 0
Deferred financing costs 0 0 0
Repayments of debt 20,000 0 0
Borrowings under revolver 0 0 0
Repayments on revolver 0 0 0
Capital contributions received (27,224) (38,458) (19,219)
Intercompany dividends paid 248,091 275,997 238,648
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest 0 0 0
Contributions from non-controlling interest     0
Proceeds from the issuance of Vector stock   0  
Proceeds from exercise of Vector options     0
Tax benefit of options exercised    
Net cash provided by (used in) financing activities 240,867 217,539 219,429
Net increase (decrease) in cash, cash equivalents and restricted cash 0 0 0
Cash, cash equivalents and restricted cash, beginning of year 0 0 0
Cash and cash equivalents and restricted cash, end of year 0 0 0
Parent/Issuer | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 188,568 177,259 135,820
Cash flows from investing activities:      
Sale of investment securities 14,673 28,761 105,815
Maturities of investment securities 24,719 101,097 10,822
Purchase of investment securities (34,445) (132,654) (117,211)
Proceeds from sale or liquidation of long-term investments 19,487 500 4,552
Purchase of long-term investments (415) (31,650)
Investments in real estate ventures 0 0 0
Distributions from real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies (280) (318) 0
Decrease in restricted assets 6 227 (15)
Issuance of notes receivable 0 (20,000)  
Investments in subsidiaries (17,224) (38,458) (19,219)
Proceeds from sale of fixed assets 0 0 0
Cash acquired in purchase of subsidiaries 0    
Purchase of subsidiaries 0 0 0
Repayment of notes receivable 20,000   0
Capital expenditures (22) (35) (86)
Investments in real estate, net 0 0 0
Pay downs of investment securities 1,611 2,633 9,212
Net cash provided by (used in) investing activities 28,110 (89,897) (6,130)
Cash flows from financing activities:      
Proceeds from issuance of debt 325,000 850,000 243,225
Deferred financing costs (9,400) (19,200) (6,600)
Repayments of debt (26,750) (835,000) 0
Borrowings under revolver 0 0 0
Repayments on revolver 0 0 0
Capital contributions received 0 0 0
Intercompany dividends paid 0 0 0
Dividends and distributions on common stock (225,367) (211,488) (198,947)
Distributions to non-controlling interest 0 0 0
Contributions from non-controlling interest     0
Proceeds from the issuance of Vector stock   43,230  
Proceeds from exercise of Vector options     398
Tax benefit of options exercised     579
Net cash provided by (used in) financing activities 63,483 (172,458) 38,655
Net increase (decrease) in cash, cash equivalents and restricted cash 280,161 (85,096) 168,345
Cash, cash equivalents and restricted cash, beginning of year 194,719 279,815 111,470
Cash and cash equivalents and restricted cash, end of year 474,880 194,719 279,815
Subsidiary Guarantors | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 204,638 171,122 139,824
Cash flows from investing activities:      
Sale of investment securities 3,955 0 10,255
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0
Proceeds from sale or liquidation of long-term investments 0 0 0
Purchase of long-term investments 0 0 0
Investments in real estate ventures 0 0 0
Distributions from real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies (484) (484) (484)
Decrease in restricted assets 520 1,783 1,177
Issuance of notes receivable 0 0  
Investments in subsidiaries 0 0 0
Proceeds from sale of fixed assets 9 76 32
Cash acquired in purchase of subsidiaries 0    
Purchase of subsidiaries (10,000) 0 0
Repayment of notes receivable 0   0
Capital expenditures (4,599) (3,705) (6,445)
Investments in real estate, net 0 0 0
Pay downs of investment securities 0 0 0
Net cash provided by (used in) investing activities (10,599) (2,330) 4,535
Cash flows from financing activities:      
Proceeds from issuance of debt 0 20,000
Deferred financing costs 0 0
Repayments of debt (21,631) (1,882) (5,226)
Borrowings under revolver 307,023 157,630 144,294
Repayments on revolver (310,551) (163,474) (110,614)
Capital contributions received 10,800 2,400 2,800
Intercompany dividends paid (176,006) (182,975) (181,709)
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest 0 0 0
Contributions from non-controlling interest     0
Proceeds from the issuance of Vector stock   0  
Proceeds from exercise of Vector options     0
Tax benefit of options exercised    
Net cash provided by (used in) financing activities (190,365) (168,301) (150,455)
Net increase (decrease) in cash, cash equivalents and restricted cash 3,674 491 (6,096)
Cash, cash equivalents and restricted cash, beginning of year 20,175 19,684 25,780
Cash and cash equivalents and restricted cash, end of year 23,849 20,175 19,684
Subsidiary Non-Guarantors | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 36,719 59,202 60,640
Cash flows from investing activities:      
Sale of investment securities 0 0 0
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0 0
Proceeds from sale or liquidation of long-term investments 0 466
Purchase of long-term investments 0 (860) (50)
Investments in real estate ventures (9,728) (38,807) (44,107)
Distributions from real estate ventures 54,233 61,718 33,204
Increase in cash surrender value of life insurance policies 0 0 0
Decrease in restricted assets 0 240 (752)
Issuance of notes receivable (450) (1,633)  
Investments in subsidiaries (10,000) 0 0
Proceeds from sale of fixed assets 0 0 13
Cash acquired in purchase of subsidiaries 654    
Purchase of subsidiaries (404) (6,569) (250)
Repayment of notes receivable 67   4,410
Capital expenditures (13,061) (16,129) (20,160)
Investments in real estate, net (2,583) (619) (245)
Pay downs of investment securities 0 0 0
Net cash provided by (used in) investing activities 18,728 (2,193) (27,937)
Cash flows from financing activities:      
Proceeds from issuance of debt 0 21 395
Deferred financing costs 0 0 0
Repayments of debt (308) (323) (139)
Borrowings under revolver 0 0 0
Repayments on revolver 0 0 0
Capital contributions received 16,424 36,058 16,419
Intercompany dividends paid (72,085) (93,022) (56,939)
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest (2,521) (2,779) (11,545)
Contributions from non-controlling interest     248
Proceeds from the issuance of Vector stock   0  
Proceeds from exercise of Vector options    
Tax benefit of options exercised     0
Net cash provided by (used in) financing activities (58,490) (60,045) (51,561)
Net increase (decrease) in cash, cash equivalents and restricted cash (3,043) (3,036) (18,858)
Cash, cash equivalents and restricted cash, beginning of year 96,043 99,079 117,937
Cash and cash equivalents and restricted cash, end of year $ 93,000 $ 96,043 $ 99,079